"Does anyone here believe that the correct answer is to allow obesity to rise because of pretty aggressive marketing of obesogenic foods to children and then stick them on GLP-1 agonists? Just relying on the drugs seems to me the wrong answer to tackling obesity."
"An estimated 1.6 million adults in England, Wales and Scotland have used drugs such as Mounjaro and Wegovy to help lose weight between early 2024 and early 2025, according to a study by UCL, highlighting the widespread adoption of these pharmaceutical interventions."
England's chief medical officer, Professor Chris Whitty, argues that relying solely on GLP-1 weight-loss drugs is insufficient for addressing the UK's obesity epidemic. He advocates for broader interventions including restrictions on junk food advertising and improvements to food healthiness. This position contrasts with health secretary Wes Streeting's recent endorsement of weight-loss drugs as transformative solutions. Research indicates approximately 1.6 million adults across England, Wales, and Scotland used GLP-1 drugs like Mounjaro and Wegovy between early 2024 and early 2025. Whitty questions whether allowing obesity rates to rise through aggressive marketing of unhealthy foods to children, then treating the consequences with pharmaceuticals, represents sound public health policy.
Read at www.independent.co.uk
Unable to calculate read time
Collection
[
|
...
]